Differentiated care to support adolescents moving into adult HIV care in Peru
Efficacy of a differentiated care intervention for adolescents transitioning to adult HIV care in Peru
A community-based program is being tested to help adolescents with HIV in Lima, Peru move successfully from pediatric to adult HIV care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11403687 on NIH RePORTER |
What this research studies
You would be offered a community-based package of support in Lima, Peru while you move from pediatric to adult HIV care. The program includes help stabilizing urgent needs (like housing), assistance with insurance and clinic transfers, accompaniment to adult clinic visits, social support groups, education and skills sessions, and mental-health screening and referrals. How long and how intense the support (about 6 or 12 months) is tailored to your adherence, viral load, family support, and readiness to transition. This work builds on a pilot with 30 adolescents in Peru that showed the approach was acceptable and improved adherence, social support, self-efficacy, and transition readiness.
Who could benefit from this research
Good fit: Adolescents living with HIV in Lima, Peru who are preparing to transition from pediatric to adult HIV services are the ideal candidates for this program.
Not a fit: People already established in adult HIV care, those living outside Lima, or those with acute inpatient or highly specialized medical needs may not benefit from this community-based intervention.
Why it matters
Potential benefit: If successful, this program could help more adolescents stay on HIV treatment and move smoothly into adult care, improving viral suppression and overall well-being.
How similar studies have performed: A recent pilot of this same intervention in Peru with 30 adolescents showed promising results, but larger-scale evidence remains limited.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Franke, Molly Forrest — Harvard Medical School
- Study coordinator: Franke, Molly Forrest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.